急性主动脉综合征并发弥漫性血管内凝血的临床研究

刘鹏, 苏德淳, 杨光, 等. 急性主动脉综合征并发弥漫性血管内凝血的临床研究[J]. 临床心血管病杂志, 2017, 33(11): 1083-1086. doi: 10.13201/j.issn.1001-1439.2017.11.015
引用本文: 刘鹏, 苏德淳, 杨光, 等. 急性主动脉综合征并发弥漫性血管内凝血的临床研究[J]. 临床心血管病杂志, 2017, 33(11): 1083-1086. doi: 10.13201/j.issn.1001-1439.2017.11.015
LIU Peng, SU Dechun, YANG Guang, et al. Clinical study of acute aortic syndrome with disseminated intravascular coagulation[J]. J Clin Cardiol, 2017, 33(11): 1083-1086. doi: 10.13201/j.issn.1001-1439.2017.11.015
Citation: LIU Peng, SU Dechun, YANG Guang, et al. Clinical study of acute aortic syndrome with disseminated intravascular coagulation[J]. J Clin Cardiol, 2017, 33(11): 1083-1086. doi: 10.13201/j.issn.1001-1439.2017.11.015

急性主动脉综合征并发弥漫性血管内凝血的临床研究

详细信息
    通讯作者: 黄日红, E-mail:dl_hrh@163.com
  • 中图分类号: R544.1

Clinical study of acute aortic syndrome with disseminated intravascular coagulation

More Information
  • 目的:通过回顾性分析急性主动脉综合征 (AAS) 合并弥漫性血管内凝血 (DIC) 患者诊断、治疗及预后。方法:回顾性分析大连医科大学附属第一医院2013-05-2017-05收治的232例AAS住院患者的临床资料。其中全部入选患者根据其是否合并DIC分为AAS合并DIC组 (AAS-DIC组) 和AAS未合并DIC组 (AAS组), 比较两组之间临床特点的差异。结果:对于入组的232例AAS患者中, 合并DIC共有19例 (8.2%), 患者预后不佳。其中10例入院时确诊DIC患者中, 5例行外科手术治疗, 3例死亡;5例保守治疗患者全部死亡。9例外科术后合并DIC患者中, 5例死亡。AAS组及AAS-DIC组DIC筛选指标均存在显著性差异, 对于外科手术术后合并DIC组, 引流量存在及ICU滞留时间存在显著差异, 但体外循环手术时间及停止循环时间方面均无明显差异。结论:AAS易导致DIC的发生, 外科手术治疗对于救治AAS合并DIC患者虽然有效, 但不能显著改善该类患者的预后。
  • 加载中
  • [1]

    孔令云, 热沙来提·斯拉吉.不典型急性主动脉夹层3例报道及文献回顾[J].临床心血管病杂志, 2017, 33 (1):99-102.

    [2]

    GERTLER J P, CAMBRIA R P, BREWSTER D C, et al.Coagulation changes during thoracoabdominal aneurysm repair[J].J Vasc Surg, 1996, 24:936-945.

    [3]

    戴仕林, 吴伟, 王贤灿, 等.78例累及主动脉弓的主动脉疾病患者弓部处理方式及早期随访结果[J].临床心血管病杂志, 2017, 33 (7):678-682.

    [4]

    KESTIN A S, VALERI C R, KHURI S F, et al.The platelet function defect of cardiopulmonary bypass[J].Blood, 1993, 82:107-117.

    [5]

    BLOME M, ISGRO F, KIESSLING A H, et al.Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery[J].Thromb Haemost, 2005, 93:1101-1107.

    [6]

    HIGASHIURA W, KICHIKAWA K, SAKAGUCHI S, et al.Deteriorating consumptive coagulopathy with type III endoleak following endovascular repair for abdominal aortic aneurysm associated with liver cirrhosis[J].J Endovasc Ther, 2007, 14:421-425.

    [7]

    KEO H H, DIEHM N, BAUMGARTNER I, et al.Disseminated intravascular coagulopathy caused by endoleak type I:successful treatment by endovascular stent-graft extension[J].Eur J Vasc Endovasc Surg, 2006, 12:98-70.

    [8]

    ADOLPH R, VORP D A, STEED D L, et al.Cellular content and permeability of intraluminal thrombus in abdominal aortic aneurysm[J].J Vasc Surg, 1997, 25:916-926.

    [9]

    Sniecinski R M, Chandler W L.Activation of the hemostatic system during cardiopulmonary bypass[J].Anesth Analg, 2011, 113:1319-1333.

    [10]

    KOSTER A, FISCHER T, PRAUS M, et al.Hemostatic activation and inflammatory response during cardiopulmonary bypass:impact of heparin management[J].Anesthesiology, 2002, 97:837-841.

    [11]

    CROSS K S, BOUCHIER-HAYES D, LEAHY A L, et al.Consumptive coagulopathy following endovascular stent repair of abdominal aortic aneurysm[J].Eur J Vasc Endovasc Surg, 2000, 19:94-95.

    [12]

    OHARA N, MIYATA T, OSHIRO H, et al.Adverse outcome following transfemoral endovascular stent-graft repair of an abdominal aortic aneurysm in a patient with severe liver dysfunction:report of a case[J].Surg Today, 2000, 30:764-767.

    [13]

    Ontachi Y, Asakura H, Arahata M, et al.Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm[J].Circ J, 2005, 69:1150-1153.

    [14]

    MAJUMDAR G.Long-term management of chronic DIC associated with inoperable aortic aneurysm with low molecular weight heparin[J].Hematol J, 2004, 5:447-448.

    [15]

    GATATE Y, MASAKI N, SATO A, et al.Tranexamic acid controlled chronic disseminated intravascular coagulation associated with aortic dissection and patent false lumen for three years[J].Intern Med, 2017, 56:925-929.

    [16]

    ONEDA K, AMANO I, TANAKA H, et al.Effective use of camostat mesilate for chronic disseminated intravascular coagulation complicated by thoracoabdominal aortic aneurysm[J].Rinsho Ketsueki, 2001, 42:30-34.

    [17]

    FUKUDA N, SHIMOHAKAMADA Y, NAKAMORI Y, et al.Thoracic aortic aneurysm with chronic disseminated intravascular coagulation treated successfully with orally administered camostat mesilate, warfarin and aspirin[J].Rinsho Ketsueki, 2014, 43:199-203.

    [18]

    KAWANO H, HATA T, UDA A, MAEMURA K.Use of rivaroxaban for the effective management of disseminated intravascular coagulation associated with abdominal aortic aneurysm[J].Intern Med, 2015, 54:2625-2628.

  • 加载中
计量
  • 文章访问数:  200
  • PDF下载数:  370
  • 施引文献:  0
出版历程
收稿日期:  2017-07-12

目录